Update in sepsis guidelines: what is really new?

Trauma Surgery & Acute Care Open
Rebecca Plevin, Rachael Callcut

Abstract

Sepsis remains a highly lethal entity resulting in more than 200 000 deaths in the USA each year. The in-hospital mortality approaches 30% despite advances in critical care during the last several decades. The direct health care costs in the USA exceed $24 billion dollars annually and continue to escalate each year especially as the population ages. The Surviving Sepsis Campaign published their initial clinical practice guidelines for the management of severe sepsis and septic shock in 2004. Updated versions were published in 2008, 2012 and most recently in 2016 following the convening of the Third International Consensus Definitions Task Force. This task force was convened by the Society of Critical Care Medicine and the European Society of Intensive Care Medicine to address prior criticisms of the multiple definitions used clinically for sepsis-related illnesses. In the 2016 guidelines, sepsis is redefined by the taskforce as a life-threatening organ dysfunction caused by a dysregulated host response to infection. In addition to using the Sequential [Sepsis-related] Organ Failure Assessment (SOFA) score to more rapidly identify patients with sepsis, the task force also proposed a novel scoring system to rapidly screen for pat...Continue Reading

Associated Clinical Trials

References

Jan 17, 2002·The New England Journal of Medicine·E RiversUNKNOWN Early Goal-Directed Therapy Collaborative Group
Dec 26, 2007·Critical Care Medicine·R Phillip DellingerUNKNOWN World Federation of Societies of Intensive and Critical Care Medicine
Oct 12, 2010·Lancet·Neill K J AdhikariGordon D Rubenfeld
Jan 29, 2013·Critical Care Medicine·R Phillip DellingerUNKNOWN Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup
Feb 28, 2013·Critical Care Medicine·David F GaieskiBrendan G Carr
Aug 30, 2013·The New England Journal of Medicine·Derek C Angus, Tom van der Poll
Nov 10, 2013·Critical Care Medicine·Elizabeth K StevensonAllan J Walkey
Mar 19, 2014·The New England Journal of Medicine·Donald M YealyDerek C Angus
Mar 19, 2014·JAMA : the Journal of the American Medical Association·Kirsi-Maija KaukonenRinaldo Bellomo
Oct 2, 2014·The New England Journal of Medicine·Lars B HolstUNKNOWN Scandinavian Critical Care Trials Group
Oct 2, 2014·The New England Journal of Medicine·Sandra L PeakePatricia Williams
Mar 18, 2015·The New England Journal of Medicine·Paul R MounceyUNKNOWN ProMISe Trial Investigators
Feb 24, 2016·JAMA : the Journal of the American Medical Association·Christopher W SeymourDerek C Angus
Feb 24, 2016·JAMA : the Journal of the American Medical Association·Mervyn SingerDerek C Angus
Apr 8, 2016·MMWR. Morbidity and Mortality Weekly Report·Lauren EpsteinAnthony Fiore
Nov 2, 2016·JAMA : the Journal of the American Medical Association·Sachin Yende, B Taylor Thompson
Dec 3, 2016·Acta Anaesthesiologica Scandinavica·S L RygårdUNKNOWN Scandinavian Critical Care Trials Group
Jan 19, 2017·Critical Care Medicine·R Phillip DellingerMitchell M Levy
Jan 20, 2017·Intensive Care Medicine·Andrew RhodesR Phillip Dellinger
Jan 24, 2017·JAMA : the Journal of the American Medical Association·Michael D Howell, Andrew M Davis
Jan 24, 2017·JAMA : the Journal of the American Medical Association·Daniel De Backer, Todd Dorman
Mar 23, 2017·The New England Journal of Medicine·UNKNOWN PRISM InvestigatorsDonald M Yealy
Mar 23, 2017·JAMA : the Journal of the American Medical Association·Yu KawazoeUNKNOWN Dexmedetomidine for Sepsis in Intensive Care Unit Randomized Evaluation (DESIRE) Trial Investigators
May 23, 2017·The New England Journal of Medicine·Christopher W SeymourMitchell M Levy

❮ Previous
Next ❯

Citations

Feb 22, 2018·MMW Fortschritte der Medizin·Beate Schumacher
Feb 22, 2018·MMW Fortschritte der Medizin·UNKNOWN Springer Medizin
Feb 22, 2018·MMW Fortschritte der Medizin·Beate Schumacher
Mar 7, 2018·MMW Fortschritte der Medizin·Elke Oberhofer
Mar 7, 2019·American Journal of Physiology. Lung Cellular and Molecular Physiology·Leah K WinerVanessa Nomellini
Aug 20, 2019·The Journal of Trauma and Acute Care Surgery·Rondi B GelbardEric Elster
Aug 3, 2017·Critical Care Nurse·JoAnn Grif Alspach
Nov 9, 2019·Biomedical Informatics Insights·Christopher R YeeVijetha Vemulapalli
Nov 15, 2019·Critical Care : the Official Journal of the Critical Care Forum·McKenzie K HollenPhilip A Efron
Sep 22, 2020·World Journal of Hepatology·Cyriac Abby PhilipsPhilip Augustine
Apr 29, 2021·Journal of Multidisciplinary Healthcare·Charles HunleyHalit O Yapici

❮ Previous
Next ❯

Methods Mentioned

BETA
sedation

Clinical Trials Mentioned

NCT01284452
NCT01448109

Software Mentioned

ARDSnet
EGDT

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Intensive Care Medicine
R Phillip DellingerSurviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup
Critical Care Medicine
R Phillip DellingerSurviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup
JAMA : the Journal of the American Medical Association
Mervyn SingerDerek C Angus
Critical Care Medicine
R Phillip DellingerWorld Federation of Societies of Intensive and Critical Care Medicine
© 2022 Meta ULC. All rights reserved